Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea.
Eui-Soon KimSun-Kyeong ParkJong-Chan YounHye Sun LeeHae-Young LeeHyun-Jai ChoJin Oh ChoiEun Seok JeonSang-Eun LeeMin-Seok KimJae-Joong KimKyung Kuk HwangMyeong-Chan ChoShung Chull ChaeSeok-Min KangJin Joo ParkYoungkeun AhnByung-Su YooJae Yeong ChoKye Hun KimByung-Hee OhBarry D GreenbergSang-Hong BaekPublished in: Journal of Korean medical science (2024)
ClinicalTrials.gov Identifier: NCT01389843.